2002
DOI: 10.1006/gyno.2001.6549
|View full text |Cite
|
Sign up to set email alerts
|

Reduced Expression of Early Growth Response-1 Gene in Leiomyoma as Identified by mRNA Differential Display

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

1
7
0

Year Published

2005
2005
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(8 citation statements)
references
References 20 publications
1
7
0
Order By: Relevance
“…In contrast, prostatic cancer (28) , gastric cancer (29) , and nasopharyngeal carcinoma cell lines (30) overexpress this gene. In our study, the EGR-1 gene expression is underexpressed consistently in all myoma tissues (Table 3), which supports the previous results (31) . We consider that EGR-1 could represent an important event in leiomygenesis, but the exact regulation mechanism of this gene in uterine leiomyoma needs further investigation.…”
Section: Discussionsupporting
confidence: 95%
See 1 more Smart Citation
“…In contrast, prostatic cancer (28) , gastric cancer (29) , and nasopharyngeal carcinoma cell lines (30) overexpress this gene. In our study, the EGR-1 gene expression is underexpressed consistently in all myoma tissues (Table 3), which supports the previous results (31) . We consider that EGR-1 could represent an important event in leiomygenesis, but the exact regulation mechanism of this gene in uterine leiomyoma needs further investigation.…”
Section: Discussionsupporting
confidence: 95%
“…Uterine leiomyomas are the most common pelvic tumors in women and are associated with various clinical problems including abnormal uterine bleeding, pelvic pain, urinary frequency, constipation, impaired fertility, and spontaneous abortion. The incidence rate of diagnosed uterine leiomyoma was 12.8 per 1000/year women in one prospective cohort of women aged [25][26][27][28][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43][44] (1) , and leiomyoma are the most commonly listed discharge diagnoses for hysterectomy in the United States (2) . Despite the clinical and public health importance of uterine leiomyoma, no certain drug treatment except surgery and no prevention method give us significant limitations for the management of these tumors.…”
mentioning
confidence: 99%
“…The molecular causes of the disease remain unknown [1][2][3][4][5][11][12][13][14] . A variety of techniques, including differential hybridization, differential display PCR, representational difference analysis, suppression subtractive hybridization (SSH), and gene array, have been used to identify the genes whose expression is selectively altered in uterine leiomyoma [1][2][3][12][13][14] . All these methods are used to analyze the mRNA expression levels of uterine leiomyoma relative genes.…”
Section: Discussionmentioning
confidence: 99%
“…Uterine leiomyomas are the most common tumor in the female genital tract, but their etiology and the molecular basis of their development and growth are unclear [1][2][3][4][5] . So it is very important to explore the molecular mechanism of the cause of uterine leiomyoma at protein level by studying the differential proteins between uterine leiomyoma and normal myometrium.…”
mentioning
confidence: 99%
“…The incidence rate of diagnosed uterine leiomyoma was 12.8 per 1000/year women in one prospective cohort of women aged [25][26][27][28][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43][44] (1) , and leiomyoma are the most commonly listed discharge diagnoses for hysterectomy in the United States (2) . Despite the clinical and public health importance of uterine leiomyoma, no certain drug treatment except surgery and no prevention method give us significant limitations for the management of these tumors.…”
mentioning
confidence: 99%